SORL1 and early-onset autosomal dominant Alzheimer disease: In summary, our goal was to apply morphological profiling via Cell Painting to differentiate wild-type NPCs from those lacking SORLA, and thus develop a drug screening assay to discover compounds for future translation for Alzheimer’s disease.